Psilocybin, the active compound in magic mushrooms, has been making waves in the scientific community and the world of personal development.

Psilocybin, the active compound in magic mushrooms, has been making waves in the scientific community and the world of personal development. While its therapeutic benefits are increasingly being recognized, one area of interest is how psilocybin affects uncomfortable emotions like shame and guilt during a psychedelic experience.
Our new longitudinal study, conducted in collaboration with Johns Hopkins University, sheds light on these emotional aspects of psilocybin use, offering new insights into the complexity of psychedelic experiences in naturalistic settings.
These findings are part of the Unlimited Sciences naturalistic psilocybin study, the largest of its kind in the world.
Conducted with 679 adults who used psilocybin in naturalistic settings, the study explored how shame and guilt manifested during psychedelic experiences and how these emotions impacted well-being both before and after the experience. Participants were surveyed before their use of psilocybin, immediately after, and then again 2-4 weeks post-experience, allowing researchers to track changes in emotional states and their potential long-term effects. In this study, psilocybin use characteristics included:
The study uncovered a variety of significant findings regarding the emotional impact of psilocybin, particularly around feelings of shame and guilt:
However, 29.8% of participants experienced an increase in trait shame, highlighting the nuanced nature of psychedelic experiences. This significant minority demonstrates that the emotional response to psilocybin can vary greatly depending on individual factors, such as mindset, environment, and past experiences.
This study highlights the emotional complexity of psilocybin experiences. The fact that a significant portion of participants experienced feelings of shame or guilt emphasizes that psychedelics, while often associated with spiritual insights or emotional healing, can also bring difficult emotions to the surface.
These findings also underscore the importance of emotional processing during psychedelic experiences. Participants who were able to confront and work through their emotions found that the outcome was a reduction in long-term shame and an overall improvement in mental well-being.
As the research into psychedelics continues to grow, studies like this one help us understand the complex emotional landscape of psychedelic experiences and offer guidance for those interested in exploring these substances for personal and therapeutic growth.
While 68.2% of participants reported feelings of shame or guilt, those who effectively processed these feelings showed improved well-being in just 2-4 weeks. And in 2-3 months following the experience, a significant reduction in the tendency to feel shame suggests psilocybin may have a lasting positive impact on emotional health.
If you’re looking for personalized guidance and support before or after a psychedelic experience, the Unlimited Sciences Psychedelic Info Line offers free, 1:1 support for answering questions about psychedelic safety, integration, and emotional processing.
Join our email list and get immediate access to our psilocybin and ayahuasca guides. You’ll also get the latest in how we’re bridging the gap between science and soul: psychedelic research updates, real-world findings, community-driven education, personal stories and expert insights on natural medicine.
Advancing Real-World Psychedelic Research and Science-Backed Education
Unlimited Sciences is provided a nonprofit status by fiscal sponsorship through Realm of Caring Foundation.
Federal EIN: 46-3371348.
© 2025 Unlimited Sciences. All Rights Reserved.
Designed by Gloss